Cargando…
Metabolic engineering of Escherichia coli BL21 (DE3) for de novo production of l-DOPA from d-glucose
BACKGROUND: Production of l-tyrosine is gaining grounds as the market size of 3,4-dihydroxyphenyl-l-alanine (l-DOPA) is expected to increase due to increasing cases of Parkinson’s disease a neurodegenerative disease. Attempts to overproduce l-tyrosine for conversion to l-DOPA has stemmed on the over...
Autores principales: | Fordjour, Eric, Adipah, Frederick Komla, Zhou, Shenghu, Du, Guocheng, Zhou, Jingwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482505/ https://www.ncbi.nlm.nih.gov/pubmed/31023316 http://dx.doi.org/10.1186/s12934-019-1122-0 |
Ejemplares similares
-
Fermentation and Metabolic Pathway Optimization to De Novo Synthesize (2S)-Naringenin in Escherichia coli
por: Zhou, Shenghu, et al.
Publicado: (2020) -
Modular Optimization of Heterologous Pathways for De Novo Synthesis of (2S)-Naringenin in Escherichia coli
por: Wu, Junjun, et al.
Publicado: (2014) -
Genome engineering Escherichia coli for L-DOPA overproduction from glucose
por: Wei, Tao, et al.
Publicado: (2016) -
Genomic and transcriptomic landscape of Escherichia coli BL21(DE3)
por: Kim, Sinyeon, et al.
Publicado: (2017) -
A systematic optimization of styrene biosynthesis in Escherichia coli BL21(DE3)
por: Liu, Changqing, et al.
Publicado: (2018)